We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
9 hedge funds and large institutions have $981K invested in Plus Therapeutics in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.02% less ownership
Funds ownership: 0.48% → 0.46% (-0.02%)
2% less capital invested
Capital invested by funds: $1M → $981K (-$21.4K)
18% less funds holding
Funds holding: 11 → 9 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ATPW
Ashton Thomas Private Wealth
Scottsdale,
Arizona
|
+$19.1K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$12K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$26.9K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$12.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.7K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$750 |